blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0628057

EP0628057 - Use of a therapeutical COMPOSITION FOR THE TREATMENT OF THERMAL INJURY [Right-click to bookmark this link]
Former [1994/50]COMPOSITIONS AND METHODS FOR THE TREATMENT OF THERMAL INJURY
[1999/42]
StatusNo opposition filed within time limit
Status updated on  18.08.2000
Database last updated on 11.09.2024
Most recent event   Tooltip11.07.2008Change - representativepublished on 13.08.2008  [2008/33]
Applicant(s)For all designated states
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
201 West Seventh Street
Austin, TX 78701 / US
[N/P]
Former [1994/50]For all designated states
BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM
201 West Seventh Street
Austin, TX 78731 / US
Inventor(s)01 / LIPSKY, Peter, E.
4406 Woodfin
Dallas, TX 75220 / US
02 / MILESKI, William, J.
2508 Canyon Creek Drive
Richardson, TX 75080 / US
[1994/50]
Representative(s)Dost, Wolfgang, et al
Bardehle Pagenberg Partnerschaft
Patentanwälte, Rechtsanwälte
Postfach 86 06 20
81633 München / DE
[N/P]
Former [2008/33]Dost, Wolfgang, et al
Patent- und Rechtsanwälte Bardehle . Pagenberg . Dost . Altenburg . Geissler Postfach 86 06 20
81633 München / DE
Former [1994/50]Dost, Wolfgang, Dr.rer.nat., Dipl.-Chem., et al
Patent- und Rechtsanwälte Bardehle . Pagenberg . Dost . Altenburg . Frohwitter . Geissler & Partner Galileiplatz 1
D-81679 München / DE
Application number, filing date93905796.405.02.1993
[1994/50]
WO1993US01030
Priority number, dateUS1992084311228.02.1992         Original published format: US 843112
[1994/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9317047
Date:02.09.1993
Language:EN
[1993/21]
Type: A1 Application with search report 
No.:EP0628057
Date:14.12.1994
Language:EN
The application published by WIPO in one of the EPO official languages on 02.09.1993 takes the place of the publication of the European patent application.
[1994/50]
Type: B1 Patent specification 
No.:EP0628057
Date:20.10.1999
Language:EN
[1999/42]
Search report(s)International search report - published on:US02.09.1993
(Supplementary) European search report - dispatched on:EP24.05.1996
ClassificationIPC:C07K16/28, A61K39/395, C12N5/20
[1999/42]
CPC:
C07K16/2845 (EP,US); C07K16/2821 (EP,US); C07K16/2854 (EP,US);
C07K16/2884 (EP,US); A61K38/00 (EP,US)
Former IPC [1994/50]C07K15/28, A61K39/395, C12N5/20
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1994/50]
TitleGerman:Verwendung einer therapeutischen ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON VERBRENNUNGEN[1999/42]
English:Use of a therapeutical COMPOSITION FOR THE TREATMENT OF THERMAL INJURY[1999/42]
French:utilisage d'une COMPOSITION therapeutique pour le TRAITEMENT DE LESIONS D'ORIGINE THERMIQUE[1999/42]
Former [1994/50]ZUSAMMENSETZUNGEN UND METHODEN ZUR BEHANDLUNG VON VERBRENNUNGEN
Former [1994/50]COMPOSITIONS AND METHODS FOR THE TREATMENT OF THERMAL INJURY
Former [1994/50]COMPOSITIONS ET PROCEDES DE TRAITEMENT DE LESIONS D'ORIGINE THERMIQUE
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase28.09.1994National basic fee paid 
28.09.1994Search fee paid 
28.09.1994Designation fee(s) paid 
28.09.1994Examination fee paid 
Examination procedure13.09.1993Request for preliminary examination filed
International Preliminary Examining Authority: US
28.09.1994Examination requested  [1994/50]
14.03.1997Despatch of a communication from the examining division (Time limit: M04)
10.06.1997Reply to a communication from the examining division
11.05.1998Despatch of communication of intention to grant (Approval: Yes)
10.09.1998Communication of intention to grant the patent
16.12.1998Fee for grant paid
16.12.1998Fee for publishing/printing paid
Opposition(s)21.07.2000No opposition filed within time limit [2000/40]
Fees paidRenewal fee
10.02.1995Renewal fee patent year 03
10.06.1996Renewal fee patent year 04
10.02.1997Renewal fee patent year 05
11.02.1998Renewal fee patent year 06
16.08.1999Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
29.02.199604   M06   Fee paid on   10.06.1996
28.02.199907   M06   Fee paid on   16.08.1999
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT20.10.1999
BE20.10.1999
CH20.10.1999
ES20.10.1999
FR20.10.1999
GR20.10.1999
IT20.10.1999
LI20.10.1999
NL20.10.1999
SE20.10.1999
DK20.01.2000
PT20.01.2000
DE21.01.2000
GB05.02.2000
IE05.02.2000
LU05.02.2000
MC29.02.2000
[2008/05]
Former [2006/14]AT20.10.1999
BE20.10.1999
CH20.10.1999
ES20.10.1999
FR20.10.1999
GR20.10.1999
LI20.10.1999
NL20.10.1999
SE20.10.1999
DK20.01.2000
PT20.01.2000
DE21.01.2000
GB05.02.2000
IE05.02.2000
LU05.02.2000
MC29.02.2000
Former [2004/39]AT20.10.1999
BE20.10.1999
CH20.10.1999
ES20.10.1999
GR20.10.1999
LI20.10.1999
NL20.10.1999
SE20.10.1999
DK20.01.2000
PT20.01.2000
DE21.01.2000
GB05.02.2000
IE05.02.2000
LU05.02.2000
MC29.02.2000
FR17.03.2000
Former [2004/07]AT20.10.1999
BE20.10.1999
CH20.10.1999
ES20.10.1999
GR20.10.1999
LI20.10.1999
NL20.10.1999
SE20.10.1999
DK20.01.2000
PT20.01.2000
DE21.01.2000
GB05.02.2000
IE05.02.2000
MC29.02.2000
FR17.03.2000
Former [2003/45]AT20.10.1999
BE20.10.1999
CH20.10.1999
ES20.10.1999
LI20.10.1999
NL20.10.1999
SE20.10.1999
DK20.01.2000
PT20.01.2000
DE21.01.2000
GB05.02.2000
IE05.02.2000
MC29.02.2000
FR17.03.2000
Former [2003/08]AT20.10.1999
BE20.10.1999
CH20.10.1999
ES20.10.1999
LI20.10.1999
NL20.10.1999
SE20.10.1999
PT20.01.2000
DE21.01.2000
GB05.02.2000
IE05.02.2000
MC29.02.2000
FR17.03.2000
Former [2002/42]AT20.10.1999
BE20.10.1999
CH20.10.1999
ES20.10.1999
LI20.10.1999
SE20.10.1999
PT20.01.2000
DE21.01.2000
GB05.02.2000
IE05.02.2000
MC29.02.2000
FR17.03.2000
Former [2002/26]AT20.10.1999
BE20.10.1999
CH20.10.1999
ES20.10.1999
LI20.10.1999
SE20.10.1999
PT20.01.2000
DE21.01.2000
GB05.02.2000
IE05.02.2000
FR17.03.2000
Former [2002/23]AT20.10.1999
BE20.10.1999
CH20.10.1999
LI20.10.1999
SE20.10.1999
PT20.01.2000
DE21.01.2000
GB05.02.2000
IE05.02.2000
FR17.03.2000
Former [2002/09]AT20.10.1999
BE20.10.1999
CH20.10.1999
LI20.10.1999
PT20.01.2000
DE21.01.2000
GB05.02.2000
IE05.02.2000
FR17.03.2000
Former [2001/17]AT20.10.1999
BE20.10.1999
CH20.10.1999
LI20.10.1999
PT20.01.2000
GB05.02.2000
IE05.02.2000
FR17.03.2000
Former [2001/12]AT20.10.1999
BE20.10.1999
CH20.10.1999
LI20.10.1999
PT20.01.2000
GB05.02.2000
FR17.03.2000
Former [2001/06]AT20.10.1999
BE20.10.1999
CH20.10.1999
LI20.10.1999
PT20.01.2000
FR17.03.2000
Former [2000/52]AT20.10.1999
BE20.10.1999
CH20.10.1999
LI20.10.1999
PT20.01.2000
Former [2000/51]AT20.10.1999
BE20.10.1999
PT20.01.2000
CH25.01.2000
LI25.01.2000
Former [2000/50]BE20.10.1999
PT20.01.2000
CH25.01.2000
LI25.01.2000
Former [2000/43]BE20.10.1999
PT20.01.2000
Documents cited:Search[DX]EP0314863  (BAYLOR COLLEGE MEDICINE [US], et al) [DX] 1-22 * page 5, line 18 - line 45 * * claim - *;
 [X]EP0387668  (BLOOD RES LAB CENTER [US]) [X] 1-13,15-20 * page 12, line 31 - line 41 * * page 13, line 57 - page 14, line 19 * * claim - *;
 [X]WO9116928  (CELLTECH LTD [GB], et al) [X] 1-22 * page 28, line 17 - page 29, line 15 * * claim - *;
 [X]WO9119511  (GEN HOSPITAL CORP [US], et al) [X] 1-22 * page 22, line 16 - line 22 * * page 23, line 17 - page 24, line 7 * * claim - *;
 [X]  - N. VEDDER ET AL., "Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA, WASHINGTON, DC, USA, (199004), vol. 87, no. 7, pages 2643 - 2646, XP002002531 [X] 1-13,15-20 * abstract *

DOI:   http://dx.doi.org/10.1073/pnas.87.7.2643
 [A]  - M. MALDONADO ET AL., "Specific changes in peripheral blood lymphocyte phenotype from burn patients. Probable origin of the thermal injury-related lymphocytopenia.", BURNS, LONDON, GB, (199106), vol. 17, no. 3, pages 188 - 192, XP000569565 [A] 1-22 * discussion *;; table V *

DOI:   http://dx.doi.org/10.1016/0305-4179(91)90101-L
 [PX]  - W. MILESKI ET AL., "Inhibition of leukocyte-endothelial adherence following thermal injury.", JOURNAL OF SURGICAL RESEARCH, SAN DIEGO, CA, USA, (199204), vol. 52, no. 4, pages 334 - 339, XP000569587 [PX] 1-22 * the whole document *
International search[Y]  - The New England Journal of Medicine, Volume 314, Number 15, issued 10 April 1986, F.D. MOORE et al.: "Neutrophil Activation in Thermal Injury as Assessed by Increased Expression of Complement Receptors", pages 948 to 953, see entire document.
 [Y]  - Journal of Clinical Investigation, Volume 81, Number 3, issued March 1988, N.B. VEDDER et al.: "A Monoclonal Antibody to the Adherence-Promoting Leukocyte Glycoprotein, CD18, Reduces Organ Injury and Improves Survival from Hemorrhagic Shock and Resuscitation in Rabbits", pages 939 to 944, see entire document.
 [Y]  - The Western Journal of Medicine, Volume 155, Number 4, issued October 1991, J.M. HARLAN et al.: "Mechanisms and Consequences of Leukocyte-Endothelial Interaction", pages 365 to 369, see entire document.
 [Y]  - International Journal of Cancer, Volume 37, issued 1986, K. SUGITA et al.: "Use of a Cocktail of Monoclonal Antibodies and Human Complement in Selective Killing of Acute Lymphocytic Leukemia Cells", pages 351 to 357, see entire document.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.